Expression of COX-2, mPGE-synthase1, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis.

Helicobacter pylori up-regulates cyclo-oxygenase-2 (COX-2) expression, which in turn is involved in tumourigenesis. Recently, a causal link between COX-2 and multidrug resistance 1( MDR-1) gene expression, implicated in cancer chemoresistance, has been demonstrated. Thus, the expression of COX-2 and the downstream enzyme involved in PGE2 biosynthesis, microsomal PGE-synthase1 (mPGES1), was correlated with P-gp, the product of MDR-1 ,a nd the anti-apoptotic protein, Bcl-xL, in gastric biopsies from patients with Hp yloriinfection and in patients with gastric cancer. In a retrospective analysis of endoscopic and pathology files, 40 Hp ylori-negative patients (Hp−) ,5 0 Hp ylori-positive patients who responded to eradication therapy (Hp+R), 84 Hp ylori-positive patients who did not respond to eradication therapy (Hp+NR), and 30 patients with gastric cancer (18 intestinal and 12 diffuse types) were selected. COX-2, mPGES1, P-gp, and Bcl-xL were detected by immunohistochemistry. COX-2, mPGES1, P-gp, and Bcl-xL expression was undetectable in gastric mucosa from Hp− patients. By contrast, COX-2 and mPGES1 expression was detected in 42% and 44% of Hp+R patients, respectively, and in up to 66% (range 63‐66%) of Hp+NR patients (p < 0.05). The expression of COX-2 and mPGES1 correlated significantly (p < 0.0001) with that of P-gp and Bcl-xL .H igh levels of COX-2, mPGES1 ,P -gp, and Bcl-xL expression were found in intestinal-type gastric cancer samples. In conclusion, Hp ylori-dependent induction of COX-2 and mPGES1 is associated with enhanced production of P-gp and Bcl-xL that may contribute to gastric tumourigenesis and resistance to therapy. Copyright  2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.